Federal Register / Vol. 73, No.
23 / Monday, February 4, 2008 / Notices 6517
Estimated average hours per response:
FR 1379a: 5 minutes; FR 1379b: 5
minutes; FR 1379c: 10 minutes.
Number of respondents: FR 1379a:
2,640; FR 1379b: 1,800; FR 1379c:
10,000.
General description of report: This
information collection is voluntary and
authorized by law (15 U.S.C. 57(a)(f)(1)).
While the individual respondent’s
information is confidential, once such
information has been aggregated, the
aggregated information is not
considered confidential. The
information may be aggregated with
responses from other respondents and
released in statistical format while
maintaining the privacy of the
individual respondents. If a respondent
provides information not specifically
solicited on the form, that information
may be exempt from disclosure under
FOIA (5 U.S.C. § 552 (b)(4), (b)(6), or
(b)(7)) upon specific request from the
respondent.
Abstract: The FR 1379 questionnaires
are sent to consumers who have filed
complaints with the Federal Reserve
against state member banks. The
information gathered on the
questionnaires is used to determine
whether consumers are satisfied with
the way the Federal Reserve Bank
handled their complaints and to solicit
suggestions for improving the complaint
investigation process.
Current Actions: The Federal Reserve
proposes to revise the FR 1379
information collection by: (1)
renumbering the current FR 1379 to FR
1379a and reducing the number of
questions from twenty–five to six, (2)
implementing a new voluntary
questionnaire, the Federal Reserve
Consumer Help Center Survey (FR
1379b) to survey consumers about the
Federal Reserve Consumer Help (FRCH)
center, the Federal Reserve System’s
new central intake center for consumer
complaints and inquiries, and (3)
implementing a new voluntary
consumer complaint form, the Federal
Reserve Consumer Help Online
Complaint Form (FR 1379c) to the FRCH
web site1 that would allow consumers
to submit their complaint or inquiry to
the FRCH center electronically. The
proposed changes would be effective
second quarter 2008.
Board of Governors of the Federal Reserve
System, January 30, 2008.
Jennifer J. Johnson,
Secretary of the Board.
ebenthall on PRODPC61 with NOTICES
[FR Doc. E8–1930 Filed 2–1–08; 8:45 am]
BILLING CODE 6210–01–S
1 See Press Release dated November 19, 2007:
www.federalreserve.gov/newsevents/press/other/
20071119a.htm.
VerDate Aug<31>2005 15:15 Feb 01, 2008 Jkt 214001
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than February
15, 2008.
A. Federal Reserve Bank of Dallas
(W. Arthur Tribble, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. William Glover Loftin, to acquire
voting shares of Capital Bancorp, Inc.,
and thereby indirectly acquire voting
shares of Commercial Capital Bank, all
of Delhi, Louisiana.
Board of Governors of the Federal Reserve
System, January 30, 2008.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E8–1946 Filed 2–1–08; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 11 a.m.–4 p.m., February
20, 2008.
Place: Audio Conference Call. The USA
toll free dial in number is 1 (866) 659–0537.
Passcode is 9933701.
Status: Open to the public, but without a
public comment period.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
most recently, August 3, 2007, and will
expire on August 3, 2009.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the conference call includes: Special
Exposure Cohort (SEC) Petition Status
Updates for Chapman Valve and Dow
Chemical; Work Group Updates;
Subcommittee on Dose Reconstruction
Update; Status of transcripts and minutes;
and Board working time and future plans and
meetings.
The agenda is subject to change as
priorities dictate.
Because there is not a public comment
period, written comments may be submitted.
Any written comments received will be
included in the official record of the meeting
and should be submitted to the contact
person below well in advance of the meeting.
Contact Person for More Information: Dr.
Lewis V. Wade, Executive Secretary, NIOSH,
CDC, 4676 Columbia Parkway, Cincinnati,
Ohio 45226, Telephone (513) 533–6825, Fax
(513) 533–6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
04FEN1
 6518 Federal Register / Vol. 73, No. 23 / Monday, February 4, 2008 / Notices

Dated: January 24, 2008. DEPARTMENT OF HEALTH AND Description: A voluntary program
Elaine L. Baker, HUMAN SERVICES which provides State Child Support
Director, Management Analysis and Services Enforcement agencies, upon their
Office, Centers for Disease Control and Administration for Children and request, access to the earned and
Prevention. Families unearned income information reported
[FR Doc. E8–2013 Filed 2–1–08; 8:45 am] to IRS by employers and financial
Submission for OMB Review; institutions. The IRS 1099 information
BILLING CODE 4163–18–P Comment Request is used to locate noncustodial parents
Title: Project 1099. and to verify income and employment.
OMB No.: 0970–0183. Respondents: State IV–D programs.

ANNUAL BURDEN ESTIMATES

Number of Average
Number of Total burden
Instrument responses per burden hours
respondents hours
respondent per response

1099 Record specifications ............................................................................. 54 12 1.96 1,270

IRS Safeguarding Certification Letter .............................................................. 54 1 .48 26

Estimated Total Annual Burden SUMMARY: The meeting of the Clinical Center, including consideration
Hours: 1,296. Pulmonary-Allergy Drugs Advisory of personnel qualifications and
Additional Information: Copies of the Committee scheduled for February 20, performance and the competence of
proposed collection may be obtained by 2008, is cancelled. This meeting was individual investigators, the disclosure
writing to the Administration for announced in the Federal Register of of which would constitute a clearly
Children and Families, Office of December 21, 2007 (72 FR 72737). unwarranted invasion of personal
Administration, Office of Information FOR FURTHER INFORMATION CONTACT: privacy.
Services, 370 L’enfant Promenade, SW., Teresa A. Watkins, Center for Drug Name of Committee: Board of Scientific
Washington, DC 20447, Attn: ACF Evaluation and Research (HFD–21), Counselors of the NIH Clinical Center.
Reports Clearance Officer. All requests Food and Drug Administration, 5630 Date: February 25, 2008.
should be identified by the title of the Fishers Lane (for express delivery, rm. Time: 8 a.m. to 5 p.m.
information collection. E-mail address: Agenda: To review and evaluate Imaging
1093), Rockville, MD 20857, 301–827– Sciences Review.
infocollection@acf.hhs.gov. 7001, FAX: 301–827–6776, e-mail: Place: National Institutes of Health,
OMB Comment: OMB is required to Teresa.Watkins@fda.hhs.gov, or FDA Building 10, 10 Center Drive, CRC—Room 4–
make a decision concerning the Advisory Committee Information Line, 2551, Bethesda, MD 20892.
collection of information between 30 1–800–741–8138 (301–443–0572 in the Contact Person: David K. Henderson, MD,
and 60 days after publication of this Washington, DC area), code Deputy Director for Clinical Care, Office of
document in the Federal Register. 3014512545. Please call the Information the Director, Clinical Center, National
Therefore, a comment is best assured of Institutes of Health, Building 10, Room 6–
Line for up-to-date information on this
1480, Bethesda, MD 20892, (301) 496–3515.
having its full effect if OMB receives it meeting.
within 30 days of publication. Written Dated: January 24, 2008.
Dated: January 29, 2008.
comments and recommendations for the Jennifer Spaeth,
Randall W. Lutter,
proposed information collection should Director, Office of Federal Advisory
Deputy Commissioner for Policy. Committee Policy.
be sent directly to the following:
[FR Doc. E8–1959 Filed 2–1–08; 8:45 am] [FR Doc. 08–465 Filed 2–1–08; 8:45 am]
Office of Management and Budget,
BILLING CODE 4160–01–S
Paperwork Reduction Project, Fax: 202– BILLING CODE 4140–01–M
395–6974, Attn: Desk Officer for the
Administration for Children and
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
Families.
HUMAN SERVICES HUMAN SERVICES
Dated: January 25, 2008.
Janean Chambers, National Institutes of Health National Institutes of Health
Reports Clearance Officer.
Clinical Center; Notice of Closed National Institute of General Medical
[FR Doc. 08–446 Filed 2–1–08; 8:45 am]
Meeting Sciences; Notice of Closed Meetings
BILLING CODE 4184–01–M
Pursuant to section 10(d) of the Pursuant to section 120(d) of the
Federal Advisory Committee Act, as Federal Advisory Committee Act, as
DEPARTMENT OF HEALTH AND amended (5 U.S.C. appendix 2), notice amended (5 U.S.C. Appendix 2), notice
HUMAN SERVICES is hereby given of a meeting of the is hereby given of the following
Board of Scientific Counselors of the meetings.
Food and Drug Administration NIH Clinical Center. The meetings will be closed to the
The meetings will be closed to the public in accordance with the
Pulmonary-Allergy Drug Advisory
public in accordance with the provisions set forth in sections
ebenthall on PRODPC61 with NOTICES

Committee; Cancellation
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
AGENCY: Food and Drug Administration, 552b(c)(6), title 5 U.S.C., as amended, as amended. The grant applications and
HHS. for the review, discussion, and the discussions could disclose
evaluation of individual intramural confidential trade secrets or commercial
ACTION: Notice.
programs and projects conducted by the property such as patentable material,

VerDate Aug<31>2005 15:15 Feb 01, 2008 Jkt 214001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\04FEN1.SGM 04FEN1